人乳头瘤病毒疫苗接种后吉兰-巴雷综合征风险:系统综述与Meta分析,2000年1月1日至2020年4月4日
该系统综述与Meta分析检索2000年1月1日至2020年4月4日发表的文献,纳入25项研究,其中7项报告相对效应量的研究被合并。HPV疫苗接种后吉兰-巴雷综合征(GBS)的合并随机效应比为1.21(95%CI:0.60-2.43),绝对和相对风险均很低且无统计学显著性,对已实施的疫苗接种项目具有安抚意义。
要点
- 7项研究的合并随机效应比为1.21(95%CI:0.60-2.43),未达统计学显著。
核心结论
- HPV疫苗接种后GBS的绝对风险和相对风险均很低且缺乏统计学显著性,这对已实施的疫苗接种项目具有安抚意义,并应用于相关沟通活动。
研究设计与样本
- 系统综述与Meta分析,检索Embase、MEDLINE和Cochrane数据库,纳入2000年1月1日至2020年4月4日发表、报告9岁及以上人群HPV疫苗接种后GBS风险的研究,排除无对照组的研究。
- 共识别602条记录,纳入25项研究,其中7项报告相对效应量的研究采用随机效应Meta分析合并,使用GRADE方法评估证据质量,研究方案注册号为PROSPERO #CRD42019123533。
主要发现
- Meta分析合并随机效应比为1.21(95%CI:0.60-2.43),异质性I²=72%(95%CI:36-88)。
临床怎么用
- 原文结论指出该结果对已实施的疫苗接种项目具有安抚意义,并应用于相关沟通活动。
局限性
- 证据质量非常低。
- 异质性I²=72%(95%CI:36-88)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundGuillain-Barré syndrome (GBS) is a rare autoimmune disease that can follow viral infections and has in a few cases been linked to vaccinations. Pre-licensure clinical trials did not observe an association between human papillomavirus (HPV) vaccination and GBS, a post-marketing study from 2017 reported an increased relative risk.AimWe assessed the risk of GBS after HPV vaccination through a systematic literature review and meta-analysis.MethodsWe searched Embase, MEDLINE and Cochrane for studies reporting on the risk of GBS after HPV vaccination in individuals aged ≥ 9 years, published between 1 January 2000 and 4 April 2020, excluding studies without a comparator group. Seven studies reporting relative effect sizes were pooled using random-effects meta-analysis. We assessed quality of evidence using the GRADE approach. Study protocol was registered (PROSPERO No. #CRD42019123533).ResultsOf 602 identified records, we included 25 studies. Based on over 10 million reports, cases of GBS were rare. In 22 studies no increased risk was observed, while in three studies a signal of increased risk of GBS after HPV vaccination was identified. Meta-analysis yielded a pooled random-effects ratio of 1.21 (95% CI: 0.60-2.43); I2 = 72% (95% CI: 36-88). This translates to a number needed to harm of one million to be vaccinated to generate one GBS case. Quality of evidence was very low.ConclusionsThe absolute and relative risk of GBS after HPV vaccination is very low and lacks statistical significance. This is reassuring for the already implemented vaccination programmes and should be used in respective communication activities.
引用
- Boender TS, Bartmeyer B, Coole L, et al. Risk of Guillain-Barré syndrome after vaccination against human papillomavirus: a systematic review and meta-analysis, 1 January 2000 to 4 April 2020. Euro Surveill. 2022. PMID: 35086611. doi:10.2807/1560-7917.ES.2022.27.4.2001619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。